Cost Effectiveness of the Shorter Course MDR TB Regimen (SCR) for multi-drug resistant tuberculosis (MDR TB) treatment

Principal investigator

Jay Achar
Purpose of study
Purpose of study

The primary outcome of this study is to compare the programmatic cost and health outcome differences between patients with rifampicin-resistant (RR) and MDR-TB treated with the SCR and those treated with conventional regimens in high TB prevalent ...

Study status

  • Concept
  • Protocol & ERB
  • Implementation
  • Completion
  • Archived

Study timeline

Documents

Publications

  • Program costs of longer and shorter tuberculosis drug regimens and drug import: A modelling study for Karakalpakstan, Uzbekistan
    Kohler, Stefan "–" European Respiratory Society (ERS) "(2022)"
  • The contribution of drug import to the cost of tuberculosis treatment: A cost analysis of longer, shorter, and short drug regimens for Karakalpakstan, Uzbekistan
    Kohler, Stefan "–" Public Library of Science (PLoS) "(2022)"
Previous study
Next study